FindTrial
Sign In

TK-642 Long-Term Administration Study

TK-642 Long-Term Administration Study

Status
Unknown
Phases
Phase 3
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT2080221269
Enrollment
Unknown
Registered
2010-10-18
Start date
2010-10-18
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Uncontrollable cancer pain

Interventions

investigational material(s) Generic name etc : TK-642 INN of investigational material : Methadone Hydrochloride Therapeutic category code : 821 Synthetic narcotics Dosage and Administration for Invest

Sponsors

TEIKOKU SEIYAKU CO., LTD.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)Patients who were successful in titration of TK-642 in TK-642 Phase 2 Study 2)Patients who can give informed consent

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Safety—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026